Amicus Therapeutics公司的背景是什麼？

詳細公司背景可參考: [https://www.amicusrx.com](https://www.amicusrx.com)。

Amicus Therapeutics

FOLD

7.945

▲0.030

▲0.32%

概況消息

最少15分鐘延遲，股票資訊由第三方資訊供應商提供

・Amicus Therapeutics - 延遲價格・最後更新於 27/05 12:14

最高位: 7.975
最低位: 7.350
開市價: --
前收市價: 7.920
成交量(千): 247.58
成交額(百萬): 14.42
買入: --
賣出: --
每手股數: --
市值(百萬): 2,225.89
市盈率: --
息率: --
差價: --
52週高低: 12.530 - 5.910

所有資料不保證絕對正確、完整、或實時，僅作為參考使用。投資涉及風險，過往業績並不代表將來表現，作任何投資決定或交易前，閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱: Amicus Therapeutics
證券代碼: FOLD.US
所屬板塊: Biotechnology
公司業務: Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio.
發行量: 278638872
公司總部: 3675 Market Street
公司網址: https://www.amicusrx.com
公司電郵: ir@amicusrx.com
公司電話: +1 215 921-7600

關於

Amicus Therapeutics(FOLD.US)所屬的行業板塊為Biotechnology。

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio.

詳細公司背景可參考: https://www.amicusrx.com。

快訊

資訊

虛擬市場

Amicus Therapeutics

企業資料

最新發佈

關於